Misoprostol
Back to searchMolecule Structure
Scientific Name
Misoprostol
Description of the Drug
Misoprostol is a prostaglandin E1 analogue used to reduce the risk of NSAID-induced gastric ulcers.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB00929
http://www.drugbank.ca/drugs/DB00929
Brand Name(s)
Cytotec, Misoprostol, Mysodelle, Topogyne
Company Owner(s)
Micro Labs Ltd, Acq Pharma Llc, Exela Holdings Inc, Sandoz Inc, Actavis Laboratories Fl Inc, Yung Shin Pharmaceutical Industrial Co Ltd, Amneal Pharmaceuticals, Novel Laboratories Inc, Ani Pharmaceuticals Inc, Pfizer Inc
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| Prostanoid EP3 receptor | SINGLE PROTEIN | AGONIST | CHEMBL3710 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL7787 | |
| PharmGKB | PA450523 | |
| Human Metabolome Database | HMDB0015064 | |
| DrugBank | DB00929 | |
| PubChem: Thomson Pharma | 14927229 | 14804742 |
| PubChem | 5282381 | |
| Nikkaji | J345.358H | |
| BindingDB | 85606 | |
| EPA CompTox Dashboard | DTXSID7020897 | |
| DrugCentral | 1817 | |
| Brenda | 145059 | |
| ChemicalBook | CB7713293 | |
| Guide to Pharmacology | 1936 | |
| rxnorm | CYTOTEC | MISOPROSTOL |
| PubChem: Drugs of the Future | 12013227 |
